8th Feb 2005 07:00
Advanced Medical Solutions Grp PLC08 February 2005 For Immediate Release 8 February, 2005 Advanced Medical Solutions Group plc ("AMS" or "the Company") Announces European regulatory approval and market introduction of advanced woundcare hydroalginate dressings with silver Winsford, UK: Advanced Medical Solutions (AIM: AMS), the global woundcaretechnology company, is pleased to announce that it has received CE mark approvalfor a range of hydroalginate woundcare dressings with silver allowing them to besold throughout Europe. The products will be marketed by Johnson & JohnsonWound Management, a division of ETHICON, INC. under the brand SILVERCEL*Hydroalginate Dressing with Silver. SILVERCEL Hydroalginate Dressings combine the potent broad spectrumantimicrobial action of silver with the absorption of alginate - a natural wounddressing derived from seaweed. On 27th June 2003, AMS announced that it had entered an exclusive supplyagreement with Johnson & Johnson Wound Management for a range of alginatewoundcare dressings containing silver, using X-STATIC(R) silver fibre technologyfrom Noble Fiber Technologies Inc. The X-STATIC silver fibre technologyutilises a layer of pure silver bonded to the surface of a textile fibre, whichprovides a reservoir for silver ion release for wounds requiring sustainedprotection and therapy and which enables it to be incorporated into the alginatedressing. AMS subsequently developed calcium alginate products, which allow acontrolled and sustained release of silver into the wound without compromisingthe performance of the alginate as an advanced woundcare dressing. On 8th July 2003, AMS announced that it had received 510(k) clearance by theFDA, allowing sale of these products into the US. It was subsequently announcedon 27th April 2004 that Johnson & Johnson Wound Management had introduced therange into this market. With the European approval and market introduction announced today, the productsare now widely available on a global basis. Commenting on today's announcement, Dr. Don Evans, Chief Executive of AMS, said: "I am delighted that this product will now be available in Europe as part of anantimicrobial wound dressings platform. With inventive products such as silveralginate dressings, we are committed to advancing wound care technology forchronic and acute wound management". "This launch is another key milestone for AMS in delivering our stated strategyof launching novel woundcare products with major global players". For further information, please contact: Advanced Medical Solutions Group plc Tel : +44 (0) 1606 545508Don Evans, Chief ExecutiveMary Tavener, Finance Directorwww.admedsol.com Buchanan Communications Tel: +44 (0) 20 7466 5000Mark Court, Mary-Jane Johnson Notes to Editors: Advanced Medical Solutions is a leading company in the development andmanufacture of products for the $15 billion global woundcare market. Founded in 1991 and currently quoted on AIM, Advanced Medical Solutions isfocused on the design, development and manufacture of innovative andtechnologically advanced products for woundcare and other medical applications. In-house natural and synthetic polymer technology is used to provide advancedwound dressings based on the moist healing principle. AMS's resources ensure aunique position as a vertically integrated 'one stop shop' to provide allcategories of moist wound healing products. The Company has the capability tomove from product design and development through to production and deliveryready for distribution into customer markets. The acquisition of MedLogic in 2002 has brought AMS products and technology incyanoacrylate based tissue adhesives that offer benefits over sutures andstaples for closing wounds sold direct to hospitals or through distributors. AMS's technology and products currently serve the majority of the key globalmarkets with strategic partners including 3M, Novartis, Johnson & Johnson,Molnlycke Healthcare, Smith + Nephew and Cardinal Health. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Advanced Medical Solutions Group